{
    "nct_id": "NCT05763563",
    "official_title": "Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy",
    "inclusion_criteria": "* Age ≥65 years\n* Lymphoma, leukemia, or myeloma with commercial FDA-approved CAR-T delivery planned for ≥4 weeks following enrollment\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Able to read and speak English fluently\n* Capable of providing informed consent\n* For optional, tele-supervised aerobic training procedure involving stationary bicycle delivery, participants must live within a 2-hour drive of Moffitt Cancer Center as determined via Google Maps.\nHealthy volunteers allowed\nMust have minimum age of 65 Years",
    "exclusion_criteria": "* Regular engagement in Resistance training (2x/week targeting all major muscle groups)\n* Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q) and Patient-Reported Measurement Information System (PROMIS) screening questions\n* Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV).\n* Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT using body weight\n* Numeric pain rating scale of ≥ 7 out of 10\n* Myopathic or rheumatologic disease that impacts physical function\n* Cognitive, visual, or auditory limitations that preclude safe engagement in remotely-supervised resistance training sessions or independent aerobic exercise (as determined by patients' treating oncologists and specified in clinic notes outlining disease history).",
    "miscellaneous_criteria": ""
}